Activation of central cannabinoid type 2 receptors, but not on peripheral immune cells, is required for endocannabinoid-mediated neuroprotection in Parkinson's disease

Thumbnail Image
1-s2.0-S0889159125001746-main.pdf (7.18 MB)
Identifiers
URI: https://hdl.handle.net/10641/6805
ISSN: 0889-1591
DOI: 10.1016/j.bbi.2025.04.037

Publication date

2025-08

Start date of the public exhibition period

End date of the public exhibition period

Authors

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

Metrics
Google Scholar
Share
Export

Research Projects

Organizational Units

Journal Issue

Doctoral program

Description

Publisher Copyright: © 2025 The Author(s)

Keywords

CD4 T cells, Cannabinoid receptor type 2, Endocannabinoid system, Microglia, Neuroprotection, Parkinson's disease, Immunology, Endocrine and Autonomic Systems, Behavioral Neuroscience, Journal Article, Yes, yes

Citation

Ayerra, L, Abellanas, M A, Vidaurre, C, Basurco, L, Tavira, A, Luquin, E, Clavero, P, Mengual, E, Collantes, M, Peñuelas, I, de Martin-Esteban, S R, Grether, U, Hillard, C J, Romero, J, Hervás-Stubbs, S & Aymerich, M S 2025, 'Activation of central cannabinoid type 2 receptors, but not on peripheral immune cells, is required for endocannabinoid-mediated neuroprotection in Parkinson's disease', Brain, Behavior, and Immunity, vol. 128, pp. 600-611. https://doi.org/10.1016/j.bbi.2025.04.037

Collections

FACULTAD DE CIENCIAS EXPERIMENTALES